Bionano Genomics, Inc. — Director's Dealing 2022

May 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2022-05-13

Reporting Person: Stewart Christopher P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-13	Common Stock	M	60000	$0.56	Acquired	121579	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-13	Stock Option (Right to Buy)	$0.56	M	60000	Disposed	2030-09-01	Common Stock (60000)	Direct

Footnotes

F1: Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021.

F2: The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.